secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001681622-23-000069
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q4 FY2023 rev $227M; Medical down 10% YoY, Industrial up 27%; guides Q1 FY2024 rev $180-$200M
--------------------------------------------------------------------------------

- Q4 revenue $227M, down 2% YoY and 2% sequentially; full-year record revenue $893M.
- GAAP EPS $0.66 per diluted share; non-GAAP EPS $0.45 per diluted share.
- Medical segment revenue down 10% YoY (China anti-corruption headwind); Industrial up 27% YoY.
- Cash from operations $47M in Q4; cash & marketable securities $195M at year-end.
- Q1 FY2024 guidance: revenue $180-$200M, non-GAAP EPS $0.00-$0.20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/0001681622-23-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162223000069/vrex-20231114.htm
  HTML page:      https://secwatch.observer/filing/0001681622-23-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer